Guided Detection of MRSA with the MolecuLight i:X™

Note: The MolecuLight i:XTM Imaging Device is available in Canada and the European Union. US FDA De Novo approval pending.

Methicillin Resistant Staphylococcus aureus (MRSA) infections are difficult to treat with standard types of antibiotics and are therefore more dangerous and costly to the healthcare system.

Clinical Synopsis: This non-healing venous leg ulcer patient presented with clinical signs and symptoms of inflammation that did not suggest bacterial presence during a routine wound care visit. However, the MolecuLight i:X Imaging Device detected the presence of red-fluorescing bacteria, prompting the clinician to swab the wound. Lab results confirmed the presence of MRSA.

Image taken in Standard Imaging ModeTM
Image taken in Standard Imaging ModeTM
Image taken in Fluorescence Imaging ModeTM (presence of bacteria indicated by red color)
Image taken in Fluorescence Imaging ModeTM
(presence of bacteria indicated by red color)

Wound Etiology
  • Venous leg ulcer
Anatomical Location
  • Left medial ankle
Patient Demographics
  • Male, 50 years old
Patient-Related Challenges
  • Non-healing ulcer
Cause of Wound
  • Trauma to leg
  • Deep vein thrombosis
Patient’s General Care Paradigm
  • Compression
  • Local wound care
Confirmed lab pathologies
  • Swab results confirmed presence of Methicillin Resistant Staphylococcus aureus (MRSA)
Clinician Stated Utility of the MolecuLight i:X
  • Distinguishing between inflammation and potential infection
  • Guided swabbing
  • Guided cleaning
Images provided by Rose Raizman RN-EC, MSc, Rouge Valley Health System, ON, Canada
MolecuLight Clinical Case 0020